XML 60 R45.htm IDEA: XBRL DOCUMENT v3.20.4
Agreements - Roche (Details)
$ in Thousands
1 Months Ended 12 Months Ended
May 03, 2019
USD ($)
Jan. 31, 2019
USD ($)
May 31, 2000
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2000
USD ($)
item
Collaborative Agreements disclosures              
Non-cash royalty revenue related to sale of future royalties       $ 68,529 $ 47,415 $ 32,154  
Revenue recognized, previously deferred       61,872 14,817 14,139  
Revenue from contract with customer       132,299 82,271 53,446  
License and milestone fees              
Collaborative Agreements disclosures              
Revenue from contract with customer       63,742 34,788 15,280  
Roche              
Collaborative Agreements disclosures              
Period in arrears to receive royalty reports and payments related to sales of Kadcyla     3 months        
Percentage of royalty payments   100.00%          
Roche | Upfront payment              
Collaborative Agreements disclosures              
Revenue from contract with customer             $ 2,000
Roche | License and milestone fees | Development and regulatory milestones              
Collaborative Agreements disclosures              
Potential milestone payments             $ 44,000
Roche | License and milestone fees | Regulatory milestones              
Collaborative Agreements disclosures              
Revenue from contract with customer $ 5,000            
Roche | Kadcyla              
Collaborative Agreements disclosures              
Non-cash royalty revenue related to sale of future royalties       68,500 $ 47,400 $ 32,200  
Revenue from contract with customer       39,000      
Roche | Kadcyla | Regulatory milestones              
Collaborative Agreements disclosures              
Potential milestone payments       5,000      
Roche | Undisclosed Target              
Collaborative Agreements disclosures              
Number of undisclosed targets with exclusive licenses | item             4
Revenue from contract with customer             $ 1,000
Potential milestone payments             38,000
Roche | Undisclosed Target | Development and regulatory milestones              
Collaborative Agreements disclosures              
Potential milestone payments             28,000
Roche | Undisclosed Target | Milestone payments              
Collaborative Agreements disclosures              
Potential milestone payments             $ 10,000
Roche | Undisclosed Target | IND application filed              
Collaborative Agreements disclosures              
Potential milestone payments       $ 1,000      
OMERS | Kadcyla              
Collaborative Agreements disclosures              
Non-cash royalty revenue related to sale of future royalties   $ 65,200          
Percentage of royalty payments   100.00%